Literature DB >> 7218263

Survival among patients with ankylosing spondylitis: a life-table analysis.

M A Khan, M K Khan, I Kushner.   

Abstract

A life-table analysis of survival was performed retrospectively on 56 white patients (49 males) with ankylosing spondylitis. The disease was diagnosed in these patients between 1934 and 1960 at a mean age of 35.2 yr. Patients were followed until December, 1975, a mean duration of 22 yr. The expected survival was calculated from life-tables for the United States population matched for sex, age, race, geographic area, and calendar year. For the first 10 yr of follow-up, there was no difference in the observed and expected survival. By 20 yr after diagnosis, 37 patients were observed to have survived whereas 46 were expected (p = 0.001). By 40 years after diagnosis, 16 were observed to have survived and 21 were expected (p = 0.063).

Entities:  

Mesh:

Year:  1981        PMID: 7218263

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  How to diagnose axial spondyloarthropathy early.

Authors:  N Barkham; H Marzo-Ortega; D McGonagle; P Emery
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

2.  Mortality in patients with ankylosing spondylitis in Argentina.

Authors:  Emilio Andres Buschiazzo; Emilce Edith Schneeberger; Fernando Andres Sommerfleck; Cesar Ledesma; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2016-07-04       Impact factor: 2.980

3.  Cervical Spinal Fracture and Other Diagnoses Associated With Mortality in Hospitalized Ankylosing Spondylitis Patients.

Authors:  Katherine D Wysham; Sara G Murray; Nancy Hills; Edward Yelin; Lianne S Gensler
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-02       Impact factor: 4.794

4.  Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?

Authors:  Florian Brunner; Andres Kunz; Ulrich Weber; Rudolf Kissling
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

5.  Time trends in incidence, clinical features, and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study.

Authors:  Kerry A Wright; Cynthia S Crowson; Clement J Michet; Eric L Matteson
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

Review 6.  Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?

Authors:  Andrew Keat; Alexander N Bennett; Karl Gaffney; Helena Marzo-Ortega; Raj Sengupta; Tamara Everiss
Journal:  Rheumatol Int       Date:  2016-12-29       Impact factor: 2.631

Review 7.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

8.  Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis.

Authors:  K Lehtinen
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

9.  Ankylosing spondylitis: recent breakthroughs in diagnosis and treatment.

Authors:  Saeed A Shaikh
Journal:  J Can Chiropr Assoc       Date:  2007-12

Review 10.  [Epidemiology and prognostic aspects of ankylosing spondylitis].

Authors:  J Braun
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.